Search

Jan E Schnitzer

from Encinitas, CA
Age ~67
Get Report
Also known as:
Jan Dr Schnitzer, Jan C Schnitzer, Jon E Schnitzer, Jan Schnitzer Dr, Tad E Schnitzer, Janina E Schnitzer, Jan E Mc, Jan R, Jane Mc
Related to:
Matilda H Kacenski, 96
Connected to:
Bertram Schnitzer, 95Daniel Schnitz, 39Harold Schnitzer, 78Joseph M Schnitzlein, 59Larry I Schnitzer, 68Oliver A Schnitzler, 59Rita Schnizer, 69John M Schnizlein, 73Adrian C Schnobrich, 45Eric G Schnoebelen, 61

Jan Schnitzer Phones & Addresses

  • Encinitas, CA
  • 4019 Carmel View Rd, San Diego, CA 92130
  • 1105 Bardell Dr, Wilmington, DE 19808 (302) 994-6813
  • Chelsea, MA
  • Huntsville, AL
  • Boston, MA

Work

Company: Sidney kimmel cancer research center 1999 to 2009 Position: Scientific director

Education

School / High School: Yale University School of Medicine 2014 to 2018

Languages

English

Interests

Exercise • Home Improvement • Reading • Gourmet Cooking • Sports • Food • Home Decoration • Health • Photograph • Cooking • Gardening • Outdoors • Electronics • Crafts • Fitness • Music • Family Values • Movies • Collecting • Christianity • Kids • Medicine • Diet • Cats • Travel • Career • Investing • Stamp Collecting • Sports Memorabilia Collecting

Industries

Research

Resumes

Resumes

Jan Schnitzer Photo 1

Adjunct Professor

View page
Location:
1475 Trabert Ranch Rd, Encinitas, CA 92024
Industry:
Research
Work:
Sidney Kimmel Cancer Research Center 1999 - 2009
Scientific Director
Proteogenomics Research Institute For Systems Medicine 1999 - 2009
Institute Director
Harvard Medical School 1996 - 1998
Associate Professor of Pathology
Harvard Medical School 1994 - 1995
Assistant Professor of Pathology
University of California, San Diego - School of Medicine 1994 - 1995
Adjunct Professor
Education:
Yale University School of Medicine 2014 - 2018
Yale University School of Medicine 1986 - 1989
University of Pittsburgh School of Medicine 1980 - 1985
Doctor of Medicine, Doctorates Princeton University 1975 - 1980
Bachelor of Science In Engineering, Bachelors, Chemical Engineering, Biology
Interests:
Exercise
Home Improvement
Reading
Gourmet Cooking
Sports
Food
Home Decoration
Health
Photograph
Cooking
Gardening
Outdoors
Electronics
Crafts
Fitness
Music
Family Values
Movies
Collecting
Christianity
Kids
Medicine
Diet
Cats
Travel
Career
Investing
Stamp Collecting
Sports Memorabilia Collecting
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jan Schnitzer
Owner
Huntsville Helium & Balloon
Huntsville Florist
Toys - Wholesale & Manufacturers
2010 Franklin St SE #B, Huntsville, AL 35801
(256) 539-8884, (256) 534-5775
Jan E. Schnitzer
President
PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE
Noncommercial Research Organization
11211 Sorrento Vly Rd SUITE X, San Diego, CA 92121
11107 Roselle St, San Diego, CA 92121
(858) 450-9999
Jan Schnitzer
Owner
Huntsville Florist
Toys - Wholesale & Manufacturers · Card Shops · Gift Shops · Souvenir & Novelty Shops · Toy Stores · Wedding Equipment & Supplies
2010 Franklin St SE, Huntsville, AL 35801
(256) 539-8884, (256) 534-5775, (256) 536-6667, (256) 539-4449

Publications

Us Patents

Immunoisolation Of Caveolae

View page
US Patent:
6737516, May 18, 2004
Filed:
Dec 9, 1998
Appl. No.:
09/208195
Inventors:
Jan E. Schnitzer - Encinitas CA, 92024
Philip Oh - San Diego CA, 92101
International Classification:
A23J 100
US Classification:
530413, 436538
Abstract:
Method of producing purified caveolae are described, in which a sample of interest comprising plasma membranes is subjected to an immunoisolation method in which the sample of interest is incubated with an antibody that is specific for caveolin and which binds to caveolin in its native (oligomeric) state, preferably for a brief time period, and caveolae that are bound to the antibody are separated from other materials in the sample of interest. Purified caveolae produced by the methods, and uses for the purified caveolae, are also described.

Isolation And Uses Of Caveolae

View page
US Patent:
20020095025, Jul 18, 2002
Filed:
Dec 11, 2000
Appl. No.:
09/734490
Inventors:
Jan Schnitzer - Encinitas CA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
C07K016/28
C12N001/00
C07K014/705
US Classification:
530/387100, 435/317100, 530/350000
Abstract:
Methods of isolating and purifying caveolae, microdomains of GPI-anchored proteins, and membranes consisting essentially of caveolae associated with microdomains of GPI-anchored proteins from endothelial cell membranes are disclosed. The methods comprise coating a luminal surface of an endothelial cell membrane with an adherent first ionic material by perfusion from a luminal cavity adjacent to the endothelial cell membrane, forming a pellicle by contacting the first ionic material with a second ionic material, and isolating and purifying the pellicle. The pellicle is then processed to isolate the desired cellular component. Caveolae which are substantially free of microdomains of GPI-anchored proteins; microdomains of GPI-anchored proteins which are substantially free of caveolae; and membranes consisting essentially of caveolae, microdomains of GPI-anchored proteins, and caveolae associated with microdomains of GPI-anchored proteins; all of which are substantially free of other cellular elements, are also disclosed.

Targeting Endothelium For Tissue-Specific Delivery Of Agents

View page
US Patent:
20040115128, Jun 17, 2004
Filed:
Jul 31, 2003
Appl. No.:
10/631481
Inventors:
Jan Schnitzer - Encinitas CA, US
International Classification:
A61K051/00
C12Q001/68
G01N033/53
US Classification:
424/001490, 435/007100, 435/006000
Abstract:
Mechanisms and routes by which molecules can be delivered into cells, particularly endothelial cells, through the action of caveolae, G domains and other plasma membrane domains and components, are described, as are delivery systems comprising antibodies to caveolar proteins or receptors and also agents conjugated to the antibody or ligand, which can be used to deliver agents to, into, and/or across the endothelium, for example, for imaging purposes.

Tissue-Specific Imaging And Therapeutic Agents Targeting Proteins Expressed On Lung Endothelial Cell Surface

View page
US Patent:
20060024231, Feb 2, 2006
Filed:
Jun 2, 2005
Appl. No.:
11/143114
Inventors:
Jan Schnitzer - Encinitas CA, US
Philip Oh - San Diego CA, US
Assignee:
Sidney Kimmel Cancer Center - San Diego CA
International Classification:
A61K 51/00
A61K 49/00
A61K 49/22
A61K 49/16
C12N 15/86
US Classification:
424001490, 424009600, 424093200, 435456000, 424009500
Abstract:
Methods of delivering an agent in a tissue-specific manner, particularly lung tissue, by targeting a protein expressed on the endothelial cell surface, are described. The methods can be used for detecting, imaging and/or treating pathologies, as well as for diagnostics.

Imaging And Therapeutic Agents Targeting Proteins Expressed On Endothelial Cell Surface

View page
US Patent:
20060024232, Feb 2, 2006
Filed:
Jun 2, 2005
Appl. No.:
11/143919
Inventors:
Jan Schnitzer - Encinitas CA, US
Philip Oh - San Diego CA, US
Assignee:
Sidney Kimmel Cancer Center - San Diego CA
International Classification:
A61K 51/00
A61K 39/395
A61K 48/00
US Classification:
424001490, 424143100, 514044000, 424009340, 424009600
Abstract:
Methods of delivering an agent in a tissue-specific manner, by targeting proteins expressed on endothelial cell surface, are described. The methods can be used for detecting, imaging and/or treating neoplasia, angiogenesis or neovasculature, as well as for diagnostics and methods of assessing treatment efficacy.

Vascular Targets For Detecting, Imaging And Treating Neoplasia Or Neovasculature

View page
US Patent:
20060024315, Feb 2, 2006
Filed:
Jun 2, 2005
Appl. No.:
11/143886
Inventors:
Jan Schnitzer - Encinitas CA, US
Philip Oh - San Diego CA, US
Assignee:
Sidney Kimmel Cancer Center - San Diego CA
International Classification:
A61K 39/395
US Classification:
424155100, 424178100
Abstract:
Methods of delivering an agent in a tissue-specific manner, by targeting annexin A1, a derivative of annexin A1, or a binding partner of annexin A1, are described. The methods can be used for detecting, imaging and/or treating neoplasia, angiogenesis or neovasculature, as well as for diagnostics and methods of assessing treatment efficacy. Antibodies to annexin A1 are also described, as are methods screening for agents altering annexin A1 activity.

Targeting Endothelium For Tissue-Specific Delivery Of Agents

View page
US Patent:
20070160531, Jul 12, 2007
Filed:
Feb 27, 2007
Appl. No.:
11/711404
Inventors:
Jan Schnitzer - Encinitas CA, US
International Classification:
A61K 51/00
A61K 49/10
A61K 48/00
A61K 9/127
US Classification:
424001490, 424009340, 424093210, 424450000
Abstract:
Mechanisms and routes by which molecules can be delivered into cells, particularly endothelial cells, through the action of caveolae, G domains and other plasma membrane domains and components, are described, as are delivery systems comprising antibodies to caveolar proteins or receptors and also agents conjugated to the antibody or ligand, which can be used to deliver agents to, into, and/or across the endothelium, for example, for imaging purposes.

Vascular Targets For Detecting, Imaging And Treating Neoplasia Or Neovasculature

View page
US Patent:
20110044893, Feb 24, 2011
Filed:
Apr 23, 2010
Appl. No.:
12/766062
Inventors:
Jan E. Schnitzer - Encinitas CA, US
Philip Oh - San Diego CA, US
International Classification:
A61M 36/00
A61P 35/00
A61K 49/06
A61K 9/127
A61K 9/14
A61K 39/395
A61K 39/00
A61K 35/12
A61K 38/43
G01N 33/53
C12N 5/02
A61K 38/00
A61K 38/22
A61K 31/7088
A61K 31/713
US Classification:
424 111, 424 91, 424 93, 424450, 424489, 4241301, 4241841, 424 937, 424 941, 435 71, 435375, 514 11, 514 97, 514 44 R, 514 44 A
Abstract:
Methods of delivering an agent in a tissue-specific manner, by targeting annexin A1, a derivative of annexin A1, or a binding partner of annexin A1, are described. The methods can be used for detecting, imaging and/or treating neoplasia, angiogenesis or neovasculature, as well as for diagnostics and methods of assessing treatment efficacy. Antibodies to annexin A1 are also described, as are methods screening for agents altering annexin A1 activity.
Control profile
Jan E Schnitzer from Encinitas, CA, age ~67 Get Report